Cargando…

Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease

BACKGROUND: While the association of congenital heart disease (CHD) and growth retardation (GR) is known, data remain limited. This study investigated the incidence of GR and its neonatal risk factors in patients with CHD using nationwide population-based claims data. METHOD: The study population wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jue Seong, Noh, O Kyu, Park, Jun Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318198/
https://www.ncbi.nlm.nih.gov/pubmed/37401493
http://dx.doi.org/10.3346/jkms.2023.38.e196
_version_ 1785067985082253312
author Lee, Jue Seong
Noh, O Kyu
Park, Jun Eun
author_facet Lee, Jue Seong
Noh, O Kyu
Park, Jun Eun
author_sort Lee, Jue Seong
collection PubMed
description BACKGROUND: While the association of congenital heart disease (CHD) and growth retardation (GR) is known, data remain limited. This study investigated the incidence of GR and its neonatal risk factors in patients with CHD using nationwide population-based claims data. METHOD: The study population was extracted from Korean National Health Insurance Service claims data from January 2002 to December 2020. We included patients diagnosed with CHD under one year of age. GR was defined as an idiopathic growth hormone deficiency or short stature on the claims data. We investigated the neonatal risk factors for GR. RESULTS: The number of patients diagnosed with CHD within the first year of birth was 133,739. Of these, 2,921 newborns were diagnosed with GR. The cumulative incidence of GR was 4.8% at 19 years of age for individuals diagnosed with CHD at infancy. In the multivariable analysis, the significant risk factors for GR were preterm birth, small for gestational age, low birth weight, respiratory distress, bronchopulmonary dysplasia, bacterial sepsis, necrotizing enterocolitis, feeding problems and cardiac procedure. CONCLUSION: Several neonatal conditions were significant risk factors for GR in CHD patients, and appropriate monitoring and treatment programs are required in CHD neonates with these factors. Considering this study is limited to claims data, further studies are warranted, including genetic and environmental factors affecting GR in CHD patients.
format Online
Article
Text
id pubmed-10318198
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-103181982023-07-05 Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease Lee, Jue Seong Noh, O Kyu Park, Jun Eun J Korean Med Sci Original Article BACKGROUND: While the association of congenital heart disease (CHD) and growth retardation (GR) is known, data remain limited. This study investigated the incidence of GR and its neonatal risk factors in patients with CHD using nationwide population-based claims data. METHOD: The study population was extracted from Korean National Health Insurance Service claims data from January 2002 to December 2020. We included patients diagnosed with CHD under one year of age. GR was defined as an idiopathic growth hormone deficiency or short stature on the claims data. We investigated the neonatal risk factors for GR. RESULTS: The number of patients diagnosed with CHD within the first year of birth was 133,739. Of these, 2,921 newborns were diagnosed with GR. The cumulative incidence of GR was 4.8% at 19 years of age for individuals diagnosed with CHD at infancy. In the multivariable analysis, the significant risk factors for GR were preterm birth, small for gestational age, low birth weight, respiratory distress, bronchopulmonary dysplasia, bacterial sepsis, necrotizing enterocolitis, feeding problems and cardiac procedure. CONCLUSION: Several neonatal conditions were significant risk factors for GR in CHD patients, and appropriate monitoring and treatment programs are required in CHD neonates with these factors. Considering this study is limited to claims data, further studies are warranted, including genetic and environmental factors affecting GR in CHD patients. The Korean Academy of Medical Sciences 2023-05-24 /pmc/articles/PMC10318198/ /pubmed/37401493 http://dx.doi.org/10.3346/jkms.2023.38.e196 Text en © 2023 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Jue Seong
Noh, O Kyu
Park, Jun Eun
Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease
title Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease
title_full Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease
title_fullStr Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease
title_full_unstemmed Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease
title_short Neonatal Risk Factors for Growth Retardation in Infants With Congenital Heart Disease
title_sort neonatal risk factors for growth retardation in infants with congenital heart disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318198/
https://www.ncbi.nlm.nih.gov/pubmed/37401493
http://dx.doi.org/10.3346/jkms.2023.38.e196
work_keys_str_mv AT leejueseong neonatalriskfactorsforgrowthretardationininfantswithcongenitalheartdisease
AT nohokyu neonatalriskfactorsforgrowthretardationininfantswithcongenitalheartdisease
AT parkjuneun neonatalriskfactorsforgrowthretardationininfantswithcongenitalheartdisease